News

Colabor Group Inc. (“Colabor” or the “Company”) (TSX: CGL) announced that it identified a cybersecurity incident on July 20 that impacted its ...
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Shares of Viking ...
A well-known over-the-counter drug found in homes across America could be more dangerous than people realize. Tylenol PM, a common nighttime pain reliever, may lead to organ failure if taken too often ...
The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...